SynthesisCancer control : journal of the Moffitt Cancer Center
Analysis of the Efficacy and Safety of Cabozantinib Monotherapy Versus Its Combination with Atezolizumab in Cancer Patients: A Systematic Review and Meta-Analysis.
Kimia Pakdaman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.